EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Utility of Spot Urinary Calcium-to-Creatinine Ratio in the Assessment of Hypercalciuria in Patients with Hypoparathyroidism

Ismael Capel, Irene Berges-Raso, Albert Cano, Lara Albert, Angela Vegas-Lorenzo, Hernan-David Alvarado, Rocío Pareja, Ruth Cano-Corres, Jaume Almirall, Maria-Assumpta Caixàs, Mercedes Rigla

AACE Endocrinology and Diabetes · 2026-08

DOI: 10.1016/j.aed.2026.07.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-08. Verfasst von Ismael Capel und 10 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients with hypoparathyroidism have an increased risk of nephrolithiasis and chronic kidney disease. Hypercalciuria is a key risk factor that requires periodic monitoring. While 24-hour urinary calcium (24hUCa) is the gold standard, its cumbersome nature limits frequent testing. This study evaluates the utility of the spot urine calcium-to-creatinine ratio (UCa/UCr) for detecting hypercalciuria in these patients.

Methods

A descriptive cross-sectional study was conducted with 14 subjects (12 post-surgical) treated with calcitriol and calcium carbonate, without thiazides. Participants provided a 24-hour urine sample and a fasting spot urine sample. Hypercalciuria was defined as > 250 mg/24h in women and > 300 mg/24h in men.

Results

Four subjects presented with hypercalciuria. UCa/UCr was significantly higher in hypercalciuric patients (0.254 vs. 0.136 mg/mg; p=0.036) and showed a positive correlation with 24hUCa (Spearman's rho: 0.701; p=0.005). The optimal UCa/UCr cutoff was 0.142 mg/mg (Youden method), with an AUC of 0.875. At this cutoff, UCa/UCr demonstrated a sensitivity of 1, specificity of 0.7, negative predictive value (NPV) of 1, and positive predictive value (PPV) of 0.57.

Conclusions

UCa/UCr is a useful screening method for hypercalciuria in hypoparathyroidism, specifically for ruling out the condition given its high NPV. While promising for routine clinical monitoring, validation in larger cohorts is necessary.

Zitieren

APA

Capel, I., Berges-Raso, I., Cano, A., Albert, L., Vegas-Lorenzo, A., Alvarado, H., Pareja, R., Cano-Corres, R., Almirall, J., Caixàs, M., & Rigla, M. (2026). Utility of Spot Urinary Calcium-to-Creatinine Ratio in the Assessment of Hypercalciuria in Patients with Hypoparathyroidism. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.07.016

Vancouver

Capel I, Berges-Raso I, Cano A, Albert L, Vegas-Lorenzo A, Alvarado H, et al. Utility of Spot Urinary Calcium-to-Creatinine Ratio in the Assessment of Hypercalciuria in Patients with Hypoparathyroidism. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.07.016

BibTeX
@article{Capel2026,
  author = {Capel, Ismael and Berges-Raso, Irene and Cano, Albert and Albert, Lara and Vegas-Lorenzo, Angela and Alvarado, Hernan-David and Pareja, Rocío and Cano-Corres, Ruth and Almirall, Jaume and Caixàs, Maria-Assumpta and Rigla, Mercedes},
  title = {Utility of Spot Urinary Calcium-to-Creatinine Ratio in the Assessment of Hypercalciuria in Patients with Hypoparathyroidism},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  doi = {10.1016/j.aed.2026.07.016}
}
Kostenlos starten →